Detalhe da pesquisa
1.
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein-Barr Virus in MS Development: A Presymptomatic Case-Control Study.
Ann Neurol
; 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38860471
2.
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.
Brain
; 147(1): 177-185, 2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37930324
3.
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage.
J Neurol Neurosurg Psychiatry
; 95(4): 325-332, 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37802637
4.
Free vitamin D3 index and vitamin D-binding protein in multiple sclerosis: A presymptomatic case-control study.
Eur J Neurol
; 29(8): 2335-2342, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582958
5.
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control study.
Eur J Neurol
; 28(9): 3072-3079, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34107122
6.
National cohort study showed that infants with Down's syndrome faced a high risk of hospitalisation for the respiratory syncytial virus.
Acta Paediatr
; 106(9): 1519-1524, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28556255
7.
Systemic inflammation and risk of multiple sclerosis - A presymptomatic case-control study.
Mult Scler J Exp Transl Clin
; 8(4): 20552173221139768, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36440320